Table 1. Clinic information of prostate cancer patients enrolled in progression-free-survival analysis.

	SPOCK3low	SPOCK3high	p-value	SPON1low	SPON1high	p-value	PTNlow	PTNhigh	p-value	TGFB3low	TGFB3high	p-value
	Age			Age			Age			Age
≤65	150	156	0.915	165	141	0.988	129	177	0.051	149	157	0.085
>65	63	67		70	60		68	62		75	55
Gleason score				Gleason score			Gleason score			Gleason score
6~7	109	165	<0.001	136	138	0.02	98	176	<0.001	126	148	0.003
8~10	104	68		99	63		99	63		98	64
PSA value				PSA value			PSA value			PSA value
>0.1	142	171	0.028	160	153	0.146	131	182	0.073	154	159	0.541
≤0.1	50	35		51	34		45	40		45	40
others	21	17		24	14		21	17		25	13
Pathology stage				Pathology stage			Pathology stage			Pathology stage
T1-T2	74	105	0.01	93	86	0.511	60	119	<0.001	78	101	0.005
T3-T4	136	116		139	113		136	116		144	108
others	3	2		3	2		1	4		2	3

^*Others means that related information were missing in the dataset.